Nilotinib-induced psoriasis in a patient of chronic myeloid leukemia responding to methotrexate

被引：4
|
作者：
Kaur, Sukhjot [1 ]
Arora, Amanjot Kaur [1 ]
Sekhon, Jagdev S. [2 ]
Sood, Neena [3 ]
机构：
[1] Dayanand Med Coll & Hosp, Dept Dermatol & Venereol, Div Oncol, Ludhiana, Punjab, India
[2] Dayanand Med Coll & Hosp, Dept Internal Med, Div Oncol, Ludhiana, Punjab, India
[3] Dayanand Med Coll & Hosp, Dept Pathol, Ludhiana, Punjab, India
来源：
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY | 2015年 / 81卷 / 02期
关键词：
REGULATORY T-CELLS; GASTROINTESTINAL STROMAL TUMOR; CHRONIC MYELOGENOUS LEUKEMIA; IMATINIB-RESISTANT; PROLIFERATION; PATHOGENESIS; MANAGEMENT; INHIBITORS; DASATINIB;
D O I：
10.4103/0378-6323.152311
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：216 / 218
页数：3
相关论文
共 50 条
  • [21] Nilotinib in the treatment of chronic myeloid leukemia
    Sacha, Tomasz
    Saglio, Giuseppe
    FUTURE ONCOLOGY, 2019, 15 (09) : 953 - 966
  • [22] Nilotinib for the treatment of chronic myeloid leukemia
    Kim, Theo Daniel
    Dorken, Bernd
    le Coutre, Philipp
    EXPERT REVIEW OF HEMATOLOGY, 2008, 1 (01) : 29 - 39
  • [23] Safe discontinuation of nilotinib in a patient with chronic myeloid leukemia: A case report
    Caocci G.
    Greco M.
    La Nasa G.
    Journal of Medical Case Reports, 8 (1)
  • [24] Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront
    Al-Dubai, Husam N.
    Yassin, Mohammed A.
    Abdulla, Mohammed A.
    Aldapt, Mahmood S.
    Ghassoub, Rola S.
    CASE REPORTS IN ONCOLOGY, 2020, 13 (02): : 664 - 667
  • [25] Effects of proprotein convertase subtilisin/kexin type 9 and nilotinib plasma concentrations on nilotinib-induced hypercholesterolaemia in patients with chronic myeloid leukaemia
    Abumiya, Maiko
    Akamine, Yumiko
    Sato, Shiori
    Takahashi, Saori
    Yoshioka, Tomoko
    Kameoka, Yoshihiro
    Takahashi, Naoto
    Miura, Masatomo
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (02) : 382 - 387
  • [26] Nilotinib in chronic myeloid leukemia: a global approach
    Annunziata, Mario
    CLINICAL MANAGEMENT ISSUES, 2012, 6 : 3 - 5
  • [27] The expanding role of nilotinib in chronic myeloid leukemia
    Kim, Theo Daniel
    le Coutre, Philipp
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (01) : 97 - 107
  • [28] Development of myasthenia gravis in a patient with chronic myeloid leukemia during treatment with nilotinib
    Sanford, David
    MacDonald, Maria
    Nicolle, Michael
    Xenocostas, Anargyros
    HEMATOLOGY REPORTS, 2014, 6 (02) : 23 - 24
  • [29] Extending the reach of nilotinib in chronic myeloid leukemia
    Mauro, Michael J.
    HAEMATOLOGICA, 2014, 99 (07) : 1123 - 1124
  • [30] Hairy Cell Leukemia Variant in a Patient With Chronic Myeloid Leukemia Receiving Nilotinib: Sequential or Coincidental?
    Gopaluni, Srivalli
    Sanyal, Soma
    Bair, Alica
    Vajpayee, Neerja
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05) : E58 - E61
12345